Long-term (up to 18 years) effects on GH/IGF-1 hypersecretion and tumour size of primary somatostatin analogue (SSTa) therapy in patients with GH-secreting pituitary adenoma responsive to SSTa
暂无分享,去创建一个
P. Caron | M. Cournot | D. Vezzosi | J. Maiza | A. Bennet | M. Matta | F. Donadille | F. Loubes-Lacroix